Boehringer Ingelheim Corp. sales and marketing update

Boehringer Ingelheim's Roxane Laboratories subsidiary began distributing Viramune (nevirapine), a non-nucleoside reverse transcriptase inhibitor, to treat HIV. The wholesale cost is $6.88 per day for...